SIRT1 activation promotes mitophagy via PINK1/Parkin, reduces oxidative stress, and decreases DPR levels in cellular models. Marginally feasible given resveratrol's failure in AD trials, but warrants testing with selective activators in C9-specific models.
Genetic or pharmacologic NRF2 activation using CDDO-EA or sulforaphane upregulates ARE gene transcription (NQO1, HO-1, GCLM), restoring redox homeostasis impaired across major neurodegenerative diseases. Prioritized as most practical near-term opportunity due to multiple clinical-stage compounds and favorable risk profile.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
# Test Preregistration: Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: Microglial TREM2 Activation as Therapeutic Target in Alzheimer's Disease
**Title:** TREM2 agonism will reduce amy...
Persona-Skeptic
# Skeptic's Evaluation: Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: TREM2 Agonism
**Weakest link:** R47H is a *loss-of-function* variant—agonism restores WT signaling, but does pharmaco...
{
"ranked_hypotheses": [
{
"title": "NRF2 Activation Provides Neuroprotection Across ALS, AD, and PD",
"description": "Genetic or pharmacologic NRF2 activation using CDDO-EA or sulfo...
NRF2 Activation Provides Neuroprotection Across AL
4 rounds · quality: 0.77
Persona-Theorist
# Test Preregistration: Therapeutic Hypotheses in Neurodegeneration
## Hypothesis 1: Microglial TREM2 Activation as Therapeutic Target in Alzheimer's Disease
**Title:** TREM2 agonism will reduce amy...
Persona-Skeptic
# Skeptic's Evaluation: Neurodegeneration Therapeutic Hypotheses
## Hypothesis 1: TREM2 Agonism
**Weakest link:** R47H is a *loss-of-function* variant—agonism restores WT signaling, but does pharmaco...
{
"ranked_hypotheses": [
{
"title": "NRF2 Activation Provides Neuroprotection Across ALS, AD, and PD",
"description": "Genetic or pharmacologic NRF2 activation using CDDO-EA or sulfo...